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Abstract 
A simple and precise and accurate RP - High performance liquid chromatography (Reverse Phase - 
HPLC) method has been developed for the estimation of Ropinirole  in tablet formulations. The 
separation was achieved on a C18 (250 x 4.6 mm) 5 - micron Hypersil BDS using a mobile phase 
consisting of a degassed mixture of 0.05 M glacial acetic acid (2.85 mL of glacial acetic acid in 1000 
mL of water) and            acetonitrile (50:50) with a flow rate of 1.0 mL/min. The mobile phase 
showed the most favorable chromatographic parameter for analysis. The detection of the constituent 
was done using UV detector at 250 nm. The retention time of ropinirole was found to be 3.987 
minutes. The method was validated for system suitability, precision, accuracy, linearity, robustness. 
The linear range for ropinirole was              4 – 12 µg / ml. The method is validated for accuracy, 
precision, linearity, specificity and robustness in accordance with ICH guidelines and revealed that 
the method established is specific, accurate, rapid, precise, reliable and reproducible for the method 
has been successfully used to analyze commercial solid dosage forms which are locally available 
0.25 mg ropinirole tablets and its percentage recovery was found to be 99.82%. 
Keywords: Ropinirole Hydrochloride (RPR), High Performance Liquid Chromatography (HPLC), 
Mobile phase, Validation. 
 
1. Introduction 
Ropinirole (RPR) is a non-ergoline dopamine 
agonist, chemically it is 4-[2-(dipropylamino) 
ethyl] -1, 3-dihydro-2H-indol-2-one monoHCL, 
is a specific D2 and D3 receptor non-ergoline 
dopamine agonist that is probably equally 
effective as L-dopa  in mild, early Parkinson’s 
disease1 . Very few high-performance liquid 
chromatographic (HPLC) methods in plasma 
were developed using ultraviolet2,3 , 
electrochemical 4 or mass spectrometric 5 
detection.  Capillary zone electrophoresis was 
used for the determination of the dissociation 
constants of RPR. It is not official in any 
pharmacopoeia. UV, LC-MS 6, Visible 
Spectrophotometric, Spectroflourimetric 
methods 7-10  have been reported for the 
estimation of RPR in dosage forms and in human 
plasma, but these methods are costly and require 
sophisticated equipments for the processing of 
drug. The present study is designed to develop a 
simple, precise and accurate reverse phase HPLC 
method with good recoveries and shorter 
retention time for the estimation of Ropinirole in 
the tablet formulations. 
 
 
2. Materials and Methods 
2.1 Materials: Ropinirole, Acetonitrile HPLC 
Grade- (E. Merck Ltd. Mumbai, INDIA), Glacial 
acetic acid, Water HPLC Grade- (E. Merck Ltd. 
Mumbai, INDIA) 
2.2 Instrument: Highperformanceliquid 
chromatography (HPLC): Model - shimadzu-
LC-10ADVP, Pump -LC-10ATVP, operates 
back pressure 5000 psi. 
Detector - UV-Visible, Analytical Balance – 
Afcoset, Vacuum filter - BV– 40, Smart 
Labtech Pvt. Ltd., Sonicator - Fast clea. 
2.3 Chromatographic Conditions: 
Chromatographic separation was performed at 
ambient temperature on a reverse phase C18 (250 
x 4.6 mm) 5-micron Hyper-sil BDS column with 
use of a filtered and degassed mobile phase 
consisting of Acetonitrile: 0.05M Glacial Acetic 
Acid containing (50:50 v/v).The flow rate of 
mobile phase was adjusted to 1.0 mL/min. The 
UV detector wavelength was set at 250 nm. The 
injection volume of the standard and sample 
solutions was 20 mcL. Run time was 8 min. 
 
2.4 Procedure 
2.4.1 Preparation of 0.05 M Glacial Acetic 
Acid: Accurately measured volume of 2.85 mL 
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of glacial acetic acid (0.05 M) was transferred to 
a 1000 mL volumetric flask containing 500 mL 
of distilled water and sonicate for 5 min and final 
volume was made with distilled water. The 
solution was filtered through 0.45 µm membrane 
filter. 
2.4.2 Preparation of Mobile Phase: A mixture 
of Acetonitrile: 0.05M Glacial Acetic Acid 
(50:50) previously filtered through 0.45µm 
membrane filter was used as a mobile phase. 
2.4.3 Preparation of Standard Stock Solution: 
25 mg of Standard Ropinirole was accurately 
weighed and transferred into a 25 mL of clean 
and dry volumetric flask. Dissolve and dilute to 
volume with mobile phase to give a solution 
containing 1 mg/mL. 
2.4.4 Preparation of Working Standard 
Solution: From the prepared stock solution 
further dilution were made in order to get 
concentrations of 4, 6,8,10, 12 ppm for the 
construction of calibration curve 
2.4.5 Preparation of Sample Solution: Twenty 
tablets were weighed and finely powdered. 
Accurately 612.35 mg of tablet powder 
equivalent to 1 mg of Ropinirole was weighed 
and transferred to a 10 mL volumetric flask 
containing 5 mL of mobile phase and sonicate 
for 30 minutes and the volume was made with 
mobile phase. The solution was filtered through 
0.45 µm membrane filter. 
5 mL of the above solution was transferred into a 
clean and dry 50 mL volumetric flask and 
volume was made with mobile phase to give a 
solution containing 10 ppm. 
2.5 Method Development: It was done by using 
different made of C18 stationary phase like 
Thermo column, octadecyl silane and Hypersil 
BDS with different ratios of mobile phase 
(Acetonitrile: 0.05M Glacial Acetic Acid) that is 
60:40, 40:60, 50:50 on each of the above 
mentioned column. It was found that C18 (250 x 
4.6 mm) 5-micron Hypersil BDS with 50:50 
ratio of mobile phase offered more advantageous 
than others. Because with this combination the 
peak shape of Ropinirole was found to be good 
and has optimum plate count and tailing. 
Individual drug solution of 20 mcL was injected 
into the column at ambient temperature at a 
concentration of 10 ppm and it was 
chromatographed for 8 min using mobile phase 
at a flow rate of 1.0 mL/min and the UV spectra 
of ropinirole was recorded at a wavelength of 
250 nm. The retention time of ropinirole was 
found to be 3.987 minutes. The overlain of 
spectra is shown in Fig.2. 
 
3. Method validation 
To confirm its suitability for its intended 
purpose, the method was validated in accordance 
with ICH guidelines, for system suitability, 
linearity, specificity, precision, accuracy, and 
limit of detection, limit of quantification, 
robustness, and solution stability. All the 
validation studies were performed by replicate 
injections of sample and standard solutions. 
3.1 Linearity and Range: Linearity was 
established for the analyte peaks from 40 -120% 
of the test concentrations and were subjected to 
linear least square regression analysis. The 
calibration and linearity equation relating Y 
(drug: peak height ratio) to X (concentration µg 
ml-1) was fitted and correlation coefficient (r2), 
slope, intercept were calculated. The intra and 
inter day linearity values were established. The 
values were tabulated in table no 1. 
3.2 System Suitability: To know reproducibility 
of the developed RP - HPLC method, system 
suitability performance parameters were 
determined by injecting standard solutions. 
Parameters such as retention time Rt), peak area, 
number of theoretical plates (N), tailing factor 
(As) were determined. The results were shown in 
Table I, indicating good performance of the 
system. 
System repeatability was determined by ten 
replicate injections of a standard solution, the 
relative standard deviation (RSD) of retention 
time and peak area of ropinirole was less than 
2.0 %. 
3.3 Detection and Quantitation limit: 
Detection and Quantitation limit were calculated 
by the method based on the standard deviation 
(σ) and slope (S) of the calibration plot, using the 
formulae LOD = 3.3 σ/ S and LOQ = 10 σ/ S. 
and were mentioned in table no.1 
3.4 Specificity of Ropinirole: Specificity was 
assessed by comparison of chromatograms 
obtained from tablets and blank solution and 
from the drug standards. Because the retention 
times of ropinirole from standard solution and 
from dosage forms were identical & no-co-
eluting peaks from diluents were observed [fig.2 
(a); fig.2 (b); fig.2(c)], the method was specific 
for quantitative estimation of drug in commercial 
formulations (table no.2). 
3.5 Accuracy: Accuracy was determined by 
recovery study. It was carried out by taking the 
known amount of drug corresponding to 80%, 
100% and 120% of the label claim of ropinirole.  
%Recovery = [(ct –cu)/ ca] × 100. 
Where ct is the total conc. of the analyte found; 
cu is the conc. of the analyte present in 
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formulation; and ca is the conc. of the pure 
analyte added to the formulation. The values 
were tabulated in the table no.3, indicating good 
accuracy of the method.  
3.6 Precision: Precision was determined by 
analyzing variation of results within the same 
day (intra day) and variation of results between 
days (inter day). Intra-day and inter-day 
precision and accuracy were evaluated by 
analyzing quality-control samples containing 
low, medium, and high concentrations of 
ropinirole 4, 8, 12 ppm. For intra-day variation, 
sets of five replicates of the three concentrations 
were analyzed on the same day; for inter-day 
variation, five replicates were analyzed on three 
different days. The values were listed in the 
table. No.4 
3.7 Robustness: In this we determined effect of 
variation of organic phase composition in mobile 
phase using 90% and 110%, effect of variation 
of flow rate using 0.9 mL/min and 1.1 mL/min 
and effect of variation of temperature using 30o 
C. For all the above system suitability 
parameters were evaluated and found to be 
within the limits, for all % RSD was less than 2.0 
%. 
 
4. Result and Discussion 
The method was carried out using C18 Hyper-sil 
BDS (250mm x 4.6mm) 5-mcm. The mobile 
phase was 0.05 M Glacial acetic acid: 
Acetonitrile (50:50) with a flow rate of 1.0 
mL/min and detection using a UV detector at 
250 nm. The retention time of ropinirole was 
found to be 3.987 min and % Recovery for 
ropinirole was 99.82. 
It shows that the method is accurate and free 
from interference of the excipients. The low 
value of standard deviation obtained confirms 
the precision of the method. A linear relationship 
was obtained in the range of 4-12 µg / ml for 
ropinirole. When pharmaceutical preparations 
containing ropinirole was analysed, the results 
obtained by the proposed method has good 
agreement with the labeled amount.  
The robustness of the method showed that there 
were no marked changes in the chromatographic 
parameters, which demonstrates that the method 
developed is robust and the data from system 
suitability studies indicate conformity to 
compendial requirement. 
 
5. Conclusion 
A new, reversed-phase HPLC method has been 
developed for the analysis of ROPINIROLE in 
marketed tablets. It was shown that the method is 
accurate, repeatable, linear, precise, specific, and 
selective, and therefore reliable. The run time is 
relatively short, i.e. 3.987 min, which enables 
rapid quantitation of many samples in routine 
and quality-control analysis of the tablet 
formulation. The same solvent was used through 
out the experimental work and no interference 
from any excipient/ placebo was observed. The 
method could therefore find practical application 
as a quality-control tool for estimation of drug in 
tablet dosage forms. 
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Table no 1.  Linearity and System 
Suitability 
Method characteristic Ropinirole 
Linearity Range ( µg / ml) 4-12  
Regression equation Y= 4.4675X+5.4148 
Retention time 4.037 
Correlation 
coefficient(r2) 0.9974 
 SD of intercept 0.146 
%RSD of peak areas 0.513 
Theoretical plates 2744.549 
Tailing factor 1.069 
LOD (ng / ml) 0.1078 
LOQ (ng / ml) 0.3268 
   *Mean of ten observations 
Table no 2. Specificity of the method 
S No. Sample name 
Average Retention 
time (minutes)a 
1 blank 2.9 (aprox.) 
2 Standard 4.037  
3 Sample  4.020 
Average of four replicate injections of four samples 
Table 3: Results of Accuracy of Ropinirole 
Drug % of spiked Level 
*Amount of 
drug added 
(mg) 
*Amount of 
drug found 
(mg) 
%*Recovery 
Statistical Analysis 
of % Recovery 
SD %RSD 
Ropinirole 
80% Sample 0.796 0.7943 99.88 0.147 0.15 
100% Sample 0.9956 0.9896 99.393 0.454 0.46
120%Sample 1.1843 1.18066 99.69 99.69 0.25
*Mean of five observations 
 
Table no. 4 Precision of Ropinirole 
Drug amount  
Con (µg / ml) 
Intra-day a Inter-dayb 
Mean ± SD %RSD Mean ± SD %RSD 
4  3.95 ± 0.022 0.5569 4.032 ± 0.064 1.5873 
8 7.96 ± 0.014 0.1758 8.034 ± 0.036 0.4480 
12 11.942 ± 0.028 0.2344 12.048 ± 0.049 0.4067 
a. Intra-day accuracy and precision were determined by five replicate analyses for each concentration 
b Inter-day accuracy and precision were determined by fifteen replicate analyses (day 1, n = 5; day 2, n = 5; 
day 3, n = 5) for each concentration 
 
Table no: 5 Results for the assay of drugs. 
Formulation 
 
Active ingredient 
(Label claim mcg) Amount found * ± SD 
%purity*  ±SD 
 
Ropin 0.25 0.247 ± 0.003 98.96  ± 1.42 
Requip 0.25 0.256 ± 0.0026 102.64 ± 1.06 
• -- a mean of 5 injections of each formulation 
  
 
 
 
Fig. 1. Structure of Ropinirole (RPR) 
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Fig. 2 
 
.  
  
 
 
Fig.2 (a). Chromatogram of blank       
 
Fig.2 (b).  Chromatogram of standard Ropinirole 
 
            
 Fig.2 (c). Chromatogram of sample Ropinirole  
 
